Fundz

Viking Therapeutics Appoints Greg Zante as Chief Financial Officer

PUBLIC · VKTXOct 29, 2026

Position

Chief Financial Officer

Company

Viking Therapeutics

Greg Zante
San DiegoBiotechnology

Description

Viking Therapeutics has appointed Greg Zante as Chief Financial Officer. This comes amid the company’s ongoing development of VK2735, an obesity treatment in Phase 3 trials.

Who to call at Viking Therapeutics, and when

A new leader at Viking Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Viking Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Viking Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Viking Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Viking Therapeutics

Location

9920 Pacific Heights Blvd,, Suite 350

San Diego, California, United States

About

Viking Therapeutics, Inc. (Nasdaq:VKTX) is a clinical-stage biopharmaceutical company focused on the development of novel 1st-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders, with two programs currently in clinical trials. Viking's clinical programs include VK2735, a novel dual agonist of the GLP-1 and GIP receptors for the potential treatment of various metabolic disorders. Data from a Phase 1 and a Phase 2 trial evaluating VK2735 (dosed subcutaneously) for metabolic disorders demonstrated an encouraging safety and tolerability profile as well as positive signs of clinical benefit. Concurrently, the company is evaluating an oral formulation of VK2735 in a Phase 2 trial.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Viking Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Marianne
Senior decision-maker at this company
••••••••@••••••••

See Marianne's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Viking Therapeutics's next move

Learn about Strategic plan

Viking Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.